NorthWest Biotherapeutics Inc (NWBO)

[DocLee]

I can't imagine that the time Prof. Liau spends working on NWBO's Scientific Advisory Board (SAB) will be unremunerated. As this will involve her in time away from her job at UCLA I have little doubt that the money that NWBO will pay for her services will be paid not to her but paid directly to her employer, UCLA, in recompense. .

I would think that UCLA are savvy enough to realise that the licences for DCVax that they issued to NWBO will increase in value as more and more medical applications for DCVax are allowed by the Regulators. Increasing the number of medical applications for the DCVax platform can only be helped by having Prof. Liau on the SAB where her advice will be solid, up-to-the-minute and dependable so that it is hard to imagine that UCLA are anything but delighted for Prof. Liau to join NWBO (and so increase the value of their licences).